Clinical Trial Detail

NCT ID NCT02831257
Title AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

meningioma

Therapies

Vistusertib

Age Groups: senior adult

No variant requirements are available.